New trial which may help us all the paper states, "Advances in our understanding of deiodinase and thyroid hormone transporter polymorphisms may ultimately enable us to provide therapy tailored to individual patients." pubmed.ncbi.nlm.nih.gov/345...
New trial using slow release T3: New trial which... - Thyroid UK
New trial using slow release T3
I think this paper has already been posted twice.
For the subset of patients not restored to baseline health with levothyroxine, causes arising from all aspects of the patient's life (co-existent medical conditions, stressors, lifestyle, psychosocial factors) should be broadly considered.
Alarm bells immediately start to ring!
How much of patient's "aspects of life" and their " co-existant medical conditions" are the consequence of poor (or no) thyroid medication, low T3, tissue hypothyroidism....but are misunderstood or unidentified as such
So, will diagnoses of FM, CFS, IBS anxiety etc etc prevail?
The greater ability (of medics) to analyse lab results would be a good start. If the posts on this forum are anything to go by the lack of that ability results in patients falling at the first hurdle.
It looks as if jumping through hoops to be correctly diagnosed and medicated is unlikely to change anytime soon!
A patient cannot be medicated properly until the cause of the illness is correctly identified and unless this happens they will not recover.
Above all we, the patients, need "therapy tailored to individual patients." They have got that right!
I hope they don't put the cart before the horse and leave patients who may benefit from slow release T3, wrongly medicated.
Hello Lyn,Thank you for posting this. I'd like to access the full report - is there any way of doing that?
Many thanks
PDS1
Thanks for posting this. Another positive step. I would very much like to try a slow release t3 🤞🏻🤞🏻🤞🏻
I do tend to dislike the psychosocial term as it seems an easy way to patient blame but that’s just me 🤷♀️